Abstract
Continuous-flow left ventricular assist devices (LVADs) are increasingly implanted to support patients with end-stage heart failure. These patients are at high risk for complications, many of which necessitate emergency care. While rehospitalization rates have been described, there is little data regarding emergency department (ED) visits. We hypothesize that ED visits are frequent and often require admission after LVAD implantation. We performed a retrospective review of patients in our health-care system followed by the advanced heart failure service for LVAD management after implantation between January 2011 and July 2015. We accounted for all ED visits in our system through February 2016, 7 months after the last implantation included. Clinically relevant demographic variables and ED visit details were recorded and analyzed to describe this population. We identified 81 patients with complete data, among whom there were 283 visits (3.49 visits/patient), occurring at a rate of approximately 7.3 ED visits per patient per year alive with LVAD. The most common reason for an ED visit is a complication related to bleeding (18% of visits), followed by chest pain (14%) and dizziness or syncope (13%). Thirty-six percent of patients were discharged from the ED without hospital admission. A growing populace with implanted LVADs represents an important population within emergency medicine. They are at risk for significant complications and frequently present to the ED. While many of these visits may be managed without hospital admission, this specialized patient group represents a potential area for improvement in provider education.
Similar content being viewed by others
References
Rose EA, Gelijns AC, Moskowitz AJ et al (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435–1443
Aaronson KD, Slaughter MS, Miller LW et al (2012) Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 125(25):3191–3200
Miller LW, Pagani FD, Russell SD et al (2007) Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357(9):885–896
Prinzing A, Herold U, Berkefeld A et al (2016) Left ventricular assist devices-current state and perspectives. J Thorac Dis 8(8):E660–E666
Forest SJ, Bello R, Friedmann P et al (2013) Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital. Ann Thorac Surg 95(4):1276–1281
Hasin T, Marmor Y, Kremers W et al (2013) Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol 61(2):153–163
Smedira NG, Hoercher KJ, Lima B et al (2013) Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival. JACC Heart Fail 1(1):31–39
Akhter SA, Badami A, Murray M et al (2015) Hospital readmissions after continuous-flow left ventricular assist device implantation: incidence, causes, and cost analysis. Ann Thorac Surg 100(3):884–889
Hernandez RE, Singh SK, Hoang DT et al (2015) Present-day hospital readmissions after left ventricular assist device implantation: a Large Single-Center Study. Tex Heart Inst J 42(5):419–429
Da Silva M, MacIver J, Rodger M et al (2016) Readmissions following implantation of a continuous-flow left ventricular assist device. J Card Surg 31(5):361–364
Hing E, Rui P (2016) Emergency department use in the country’s five most populous states and the total United States, 2012. Hyattsville: National Center for Health Statistics. Accessed Sept 23, 2017
Demirozu ZT, Radovancevic R, Hochman LF et al (2011) Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 30(8):849–853
Harvey L, Holley CT, John R (2014) Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention. Ann Cardiothorac Surg 3(5):475–479
Mehra MR, Naka Y, Uriel N et al (2017) A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med 376(5):440–450
Acknowledgements
Statistical support was provided by James Proudfoot, MS, at the Clinical and Translational Research Institute at University of San Diego California. OÖB was supported by the Swedish Heart–Lung Foundation, the Crafoords Foundation, Märta Winklers Stiftelse, and Thorsten Westerströms Stiftelse. MB was supported by the College of Physician and Surgeons of Ancona, Italy.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was approved by the Institutional Review Board prior to data collection.
Statement of human and animal rights
The study was approved by the Institutional Review Board prior to data collection
Informed consent
For this type of study, formal consent was not required
Rights and permissions
About this article
Cite this article
Tainter, C.R., Braun, O.Ö., Teran, F. et al. Emergency department visits among patients with left ventricular assist devices. Intern Emerg Med 13, 907–913 (2018). https://doi.org/10.1007/s11739-017-1776-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-017-1776-8